These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Febrile neutropenia (FN) in children with acute myeloid leukemia]. Ivanova LF; Dmitrieva NV; Popa AV; Bagirova NS; Durnov LA Vopr Onkol; 2001; 47(4):493-5. PubMed ID: 11710300 [No Abstract] [Full Text] [Related]
4. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group. Ozkaynak MF; Krailo M; Chen Z; Feusner J Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544 [TBL] [Abstract][Full Text] [Related]
5. Neutropenia: state of the knowledge part I. Nirenberg A; Bush AP; Davis A; Friese CR; Gillespie TW; Rice RD Oncol Nurs Forum; 2006 Nov; 33(6):1193-201. PubMed ID: 17149402 [TBL] [Abstract][Full Text] [Related]
6. What you need to know about fever and neutropenia. Syrop J Oncology (Williston Park); 2007 Oct; 21(11 Suppl Nurse Ed):2 p following 40. PubMed ID: 18154210 [No Abstract] [Full Text] [Related]
7. Empirical antimicrobial treatment for chemotherapy-induced febrile neutropenia. Bal AM; Gould IM Int J Antimicrob Agents; 2007 May; 29(5):501-9. PubMed ID: 17346939 [TBL] [Abstract][Full Text] [Related]
9. Infection prophylaxis in the patient with cancer. Carlson AC Oncol Nurs Forum; 1985; 12(3):56-64. PubMed ID: 3923452 [No Abstract] [Full Text] [Related]
10. Immediate vs. delayed imipenem treatment in cancer patients with profound neutropenia induced by high-dose chemotherapy: results of a randomized study. García-Sáenz JA; Martín M; Casado A; Pérez-Segura P; Manrique I; Flores L; Macias JA; Cámara JC; Perezagua C; Díaz-Rubio E Rev Esp Quimioter; 2002 Sep; 15(3):257-63. PubMed ID: 12582429 [TBL] [Abstract][Full Text] [Related]
11. [Guidelines for prevention of febrile neutropenia]. Barroso S; Damasceno M; Dinis J; Gervásio H; da Luz R; Passos-Coelho JL; Sá A; Costa L; Rodrigues H; Andrade S; Macedo A; Moital I Acta Med Port; 2008; 21(1):7-19. PubMed ID: 18489831 [TBL] [Abstract][Full Text] [Related]
12. When the risk of febrile neutropenia is 20%, prophylactic colony-stimulating factor use is clinically effective, but is it cost-effective? Adams JR; Angelotta C; Bennett CL J Clin Oncol; 2006 Jul; 24(19):2975-7. PubMed ID: 16682722 [No Abstract] [Full Text] [Related]
13. [Anemia and neutropenia in oncologic patients: modern growth factors simplify therapy]. Lüftner D; Jozereau D Pflege Z; 2003 Nov; 56(11):784-7. PubMed ID: 14679633 [No Abstract] [Full Text] [Related]
14. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors. Kebudi R; Görgün O; Ayan I; Gürler N; Akici F; Töreci K Med Pediatr Oncol; 2001 Apr; 36(4):434-41. PubMed ID: 11260566 [TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy-induced febrile neutropenia: about 200 episodes. Clinical, microbiological and therapeutic characteristics]. Gharbi O; Ben Hadj Hassen S; Kaabia N; Limam S; Hadj Amor M; Ben Fatma L; Landolsi A; Hochlef M; Letaief A; Boukadida J; Ben Ahmed S Pathol Biol (Paris); 2008 May; 56(3):154-7. PubMed ID: 18178025 [TBL] [Abstract][Full Text] [Related]
16. Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Pilot study phase I. Mego M; Ebringer L; Drgona L; Mardiak J; Trupl J; Greksak R; Nemova I; Oravcova E; Zajac V; Koza I Neoplasma; 2005; 52(2):159-64. PubMed ID: 15800715 [TBL] [Abstract][Full Text] [Related]
17. Outpatient management of febrile neutropenia: is it safe yet? Johnson TN; DeJesus YA; McMahon L; Rolston KV; Row MB J Support Oncol; 2008; 6(5):219-20. PubMed ID: 18551857 [No Abstract] [Full Text] [Related]
18. Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia. Baskaran ND; Gan GG; Adeeba K; Sam IC Int J Infect Dis; 2007 Nov; 11(6):513-7. PubMed ID: 17459753 [TBL] [Abstract][Full Text] [Related]
19. Bacteremia in patients with febrile neutropenia following chemotherapy. Vandijck DM; Depuydt PO; Benoit DD; Blot SI; Decruyenaere JM Int J Infect Dis; 2008 Jul; 12(4):449. PubMed ID: 18248753 [No Abstract] [Full Text] [Related]
20. Should the indications for the use of myeloid growth factors for the prevention of febrile neutropenia in cancer patients be extended? Klastersky J; Awada A; Aoun M; Paesmans M Curr Opin Oncol; 2009 Jul; 21(4):297-302. PubMed ID: 19509500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]